Industry:Biotech & Pharma
Emmaus Life Sciences Inc
Emmaus Life Sciences Inc (EMMA:US)
is pending listing
Emmaus Holdings Inc. is engaged in the discovery, development and commercialization of treatments and therapies for rare diseases. The Company's primary focus is the late-stage development of the amino acid L-glutamine as a prescription drug for the treatment of sickle cell disease ("SCD").